Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation

S Shukla, BL Tekwani - Frontiers in pharmacology, 2020 - frontiersin.org
Histone deacetylases (HADC) are the enzymes that remove acetyl group from lysine residue
of histones and non-histone proteins and regulate the process of transcription by binding to …

Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine

H Chaytow, KME Faller, YT Huang… - Cell Reports Medicine, 2021 - cell.com
Spinal muscular atrophy (SMA) is a devastating childhood motor neuron disease that, in the
most severe cases and when left untreated, leads to death within the first two years of life …

Transplantation of fecal microbiota rich in short chain fatty acids and butyric acid treat cerebral ischemic stroke by regulating gut microbiota

R Chen, Y Xu, P Wu, H Zhou, Y Lasanajak… - Pharmacological …, 2019 - Elsevier
The gut microbiota and its short chain fatty acid (SCFA) metabolites have been established
to play an important protective role against neurodegenerative diseases. Our previous study …

Induced pluripotent stem cells from a spinal muscular atrophy patient

AD Ebert, J Yu, FF Rose Jr, VB Mattis, CL Lorson… - Nature, 2009 - nature.com
Spinal muscular atrophy is one of the most common inherited forms of neurological disease
leading to infant mortality. Patients have selective loss of lower motor neurons resulting in …

Spinal muscular atrophy

MR Lunn, CH Wang - The Lancet, 2008 - thelancet.com
Spinal muscular atrophy is an autosomal recessive neurodegenerative disease
characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles …

Spinal muscular atrophy: the past, present, and future of diagnosis and treatment

H Nishio, ETE Niba, T Saito, K Okamoto… - International Journal of …, 2023 - mdpi.com
Spinal muscular atrophy (SMA) is a lower motor neuron disease with autosomal recessive
inheritance. The first cases of SMA were reported by Werdnig in 1891. Although the …

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder

CT Chiu, Z Wang, JG Hunsberger, DM Chuang - Pharmacological reviews, 2013 - ASPET
The mood stabilizers lithium and valproic acid (VPA) are traditionally used to treat bipolar
disorder (BD), a severe mental illness arising from complex interactions between genes and …

Multiple roles of HDAC inhibition in neurodegenerative conditions

DM Chuang, Y Leng, Z Marinova, HJ Kim… - Trends in neurosciences, 2009 - cell.com
Histone deacetylases (HDACs) play a key role in homeostasis of protein acetylation in
histones and other proteins and in regulating fundamental cellular activities such as …

[HTML][HTML] Insights into the activation mechanism of class I HDAC complexes by inositol phosphates

PJ Watson, CJ Millard, AM Riley, NS Robertson… - Nature …, 2016 - nature.com
Abstract Histone deacetylases (HDACs) 1, 2 and 3 form the catalytic subunit of several large
transcriptional repression complexes. Unexpectedly, the enzymatic activity of HDACs in …

Spinal muscular atrophies

BT Darras, JA Markowitz, UR Monani… - … disorders of infancy …, 2015 - Elsevier
Spinal muscular atrophies (SMAs) are hereditary degenerative disorders of lower motor
neurons associated with progressive muscle weakness and atrophy. Proximal 5q SMA is …